Cystagon
NDC 0378-9045, cysteamine bitartrate, capsule, from Mylan Pharmaceuticals Inc..
- Product NDC
- 0378-9045
- Status
- Listed
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020392
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYSTEAMINE BITARTRATE150 mg/1
Pharmacologic classes
Cystine Depleting Agent [EPC]; Cystine Disulfide Reduction [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0378-9045-05 | 00378904505 | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-9045-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f495b76d-96c6-48e5-8fa3-30a4336628eb
Use it
Look up 0378-9045 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0378-9045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.